What is AMRN's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.01B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for AMRN?

P/E (TTM) is n/a and 52-week range is $11.25 to $20.90 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s AMRN figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for AMRN?

The company profile lists revenue (TTM) near $7M, net income (TTM) near -$98M, EPS (TTM) near -$0.07 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Amarin Corporation PLC based, and what identifiers does Chartloom list?

The company context section lists headquarters in Dublin, IE, 21M shares outstanding, ISIN US0231114044 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Amarin Corporation PLC

$AMRN

Health Care · Biotechnology

IR Run Scenarios

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. The firm is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The firm operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The firm sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Employees

Website

amarincorp.com/

IPO

1993-04-01

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (price / listing EPS)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

NASDAQ NMS - GLOBAL MARKET

ISIN

US0231114044

Headquarters

Dublin, IE

Shares outstanding

21M

NAICS sector

Manufacturing

Institutional ownership

20.44%

Browse other companiesFree AI scores and summaries for more stocks

Amarin Corporation PLC (AMRN) Stock Analysis & Quote